SCHEMBL1710347

SCHEMBL1710347

CC1CNCC(N(C(=O)O)c2ccncc2N)C1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
MEN1 O00255 1/20 0.39
KDM6B O15054 1/20 0.39
KDM4A O75164 1/20 0.39
MAPT P10636 1/20 0.39
THRB P10828 1/20 0.39
KMT2A Q03164 1/20 0.39
KDM4D Q6B0I6 1/20 0.39
KDM4C Q9H3R0 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
GAA P10253 2/20 0.36
GLA P06280 1/20 0.36
PCSK9 Q8NBP7 2/20 0.35
CHRNB2 P17787 1/20 0.31
CHRNB4 P30926 1/20 0.31
CHRNA3 P32297 1/20 0.31
CHRNA4 P43681 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3231822 1.00 KDM4E (0.39) KDM4EALDH1A1MEN1KDM6BKDM4A
SCHEMBL1710277 0.86 NAMPT (0.33) KDM4EALDH1A1GAAGLAPCSK9
SCHEMBL3410717 0.85 KDM4E (0.39) KDM4EALDH1A1MEN1KDM6BKDM4A
SCHEMBL3410722 0.85 KDM4E (0.39) KDM4EALDH1A1MEN1KDM6BKDM4A
SCHEMBL3414887 0.85 KDM4E (0.39) KDM4EALDH1A1MEN1KDM6BKDM4A
SCHEMBL3414976 0.85 KDM4E (0.37) KDM4EALDH1A1MEN1KDM6BKDM4A
SCHEMBL1710402 0.85 KDM4E (0.39) KDM4EALDH1A1MEN1KDM6BKDM4A
SCHEMBL3414980 0.85 KDM4E (0.37) KDM4EALDH1A1MEN1KDM6BKDM4A
SCHEMBL1710400 0.85 KDM4E (0.39) KDM4EALDH1A1MEN1KDM6BKDM4A
SCHEMBL3232429 0.83 KDM4E (0.35) KDM4EALDH1A1MEN1KDM6BKDM4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016010897-A1 BICYCLIC HETEROAROMATIC CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS INCYTE CORPORATION (US) 2016-01-21 WO disclosed
EP-2344473-A1 HETEROCYCLIC PIM-KINASE INHIBITORS Novartis AG (CH) 2011-07-20 EP disclosed
EP-2262802-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE Novartis AG (CH) 2010-12-22 EP disclosed
WO-2010026122-A1 HETEROCYCLIC PIM-KINASE INHIBITORS NOVARTIS AG (CH) 2010-03-11 WO disclosed
WO-2009109576-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE NOVARTIS AG (CH) 2009-09-11 WO disclosed